Concierge Medicine 2.0 by Castle Connolly Private Health Partners
Practice Growth
Concierge Medicine
Business of Cardiology
Implementing the Topcon Ocular Telehealth Platform
Malpractice
Influenza
Sexual Health
Chronic Conditions
Technology
Legal and Policy
Money
Opinion
Vaccines
Practice Management
Patient Relations
Careers
Advertisement
Linagliptin cardiovascular safety profile appears superior to glimepiride
Article
Cardiovascular events were fewer in patients with type 2 diabetes randomized to 2 years of the DPP-4 inhibitor linagliptin compared with glimepiride as add-on therapy to metformin, according to data from a phase III study.